Physician profile
Amrinder Singh
NPI 1174963078
$3,976.51
in general payments reported to CMS, 2019-2025
13 companies · $373 in 2025
The $373 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $74.35 · 2021: $104 · 2022: $20.46 · 2023: $2,168 · 2024: $1,127 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,301 · Food and Beverage: $1,368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,300.77 |
| Food and Beverage | $1,367.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,881.04 | 2019-2024 | Surpass Evolve, Axs Vecta 71 |
| Imperative Care, INC | $707.49 | 2023-2025 | Zoom 88-T Large Distal Platform, Zoom Rdl Radial Access System, 103cm |
| Microvention, INC. | $616.95 | 2024 | Web Aneurysm Embolization System |
| Depuy Synthes Sales INC. | $188.33 | 2019-2021 | |
| Medtronic, INC. | $122.85 | 2022-2024 | Rist, Pipeline, Solitaire X |
| Penumbra, INC. | $106.18 | 2024 | Benchmark |
| Genzyme Corporation | $102.31 | 2023 | |
| Contego Medical, INC | $90.02 | 2025 | |
| Abbvie INC. | $61.39 | 2025 | |
| Qapel Medical INC | $38.57 | 2024 | |
| Medtronic Vascular, INC. | $30.80 | 2019-2020 | |
| Sk Life Science, INC. | $15.58 | 2023 | |
| Janssen Scientific Affairs, LLC | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amrinder Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.